Medical device maker Medtronic (MDT) is set to report its fiscal Q2 results early Tuesday, with Wall Street expecting modest EPS growth as the company retrenches. Analysts polled by Thomson Reuters estimate profit for the quarter ended Oct. 26 rose 5% over the year-ago quarter to 88 cents a share. They estimate sales fell 2% to $4.05 billion. Medtronic has been facing headwinds in the U.S., leading it to seek its fortunes abroad. Last week the